Minimally invasive focal therapies for prostate cancer are associated with a lower overall cost and improved quality of life for patients. These are the findings of a new study, published recently in ...

NEW YORK, June 8, 2026 /PRNewswire/ -- Just two days after his minimally invasive prostate cancer treatment at NYU Langone Health, Broadway performer André De Shields, 80, was back on stage preparing ...

Patients who underwent focal cryotherapy for localized prostate cancer had a 74% rate of failure-free survival at 5 years and low rates of treatment-related declines in urinary and sexual function.

While the use of focal therapy for nonmetastatic prostate cancer is limited, half of procedures occurred in settings that are not supported by current guidelines, according to a retrospective study.

Just two days after his minimally invasive prostate cancer treatment at NYU Langone Health, Broadway performer André De Shields, 80, was back onstage preparing for his next show, Cats: The Jellicle ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Newswise — Focal therapy (FT) for localized prostate cancer (PCa) has evolved into a precision-based alternative to radical treatments, aiming to eradicate clinically significant disease while ...

Compared with surgery and radiation, focal therapy improves quality of life as well as decreases financial toxicity for patients with prostate cancer. Minimally invasive focal therapies result in ...

Treatment shows early promise in treating disease and preserving potency. Although the traditional approach to prostate cancer has been to target the entire gland, Cleveland Clinic has offered focal ...

A 58-year-old businessman walks into a clinic for a routine health check. He feels fine. No pain, no urinary trouble, nothing ...

The milestone reflects growing use of targeted therapies in prostate cancer care NEW YORK, June 8, 2026 /PRNewswire/ -- Just two days after his minimally invasive prostate cancer treatment at NYU ...

Current guidelines recommend that focal therapy be reserved for patients with intermediate-risk prostate cancer within clinical trials or prospective registries. In a retrospective study, half of ...